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The role of bronchoscopy in diagnosis of chronic cough in adults: 
a retrospective single-center study
Abstract
Introduction: Cough is one of the most frequent symptoms reported to pulmonologists. The role of bronchoscopy in the diagnostic 
work-up of chronic cough is not clearly defined. The aim of this study was to evaluate the utility of fiberoptic bronchoscopy (FOB) 
and additional testing of samples collected during FOB in the differential diagnosis of chronic cough in adults.
Material and methods: This was a single-center retrospective study. Out of 7115 conventional white light FOB examinations, 
we finally selected 198 with cough as the only indication.
Results: In 40.9% of bronchoscopic examinations, no visible cause of cough was found. Visual signs of chronic bronchitis (CB) 
were detected in 57.6% of reports. Only in 3 cases (1.5%) bronchoscopy revealed a potential cause of chronic cough other than 
CB. Mycobacterium tuberculosis or other mycobacteria were spotted in none of the samples. In 91.1% of bronchoalveolar lavage 
(BAL) cytologic examinations, at least one cell count abnormality was detected, but only in case of increased percentage of 
eosinophils, it might be considered clinically relevant. In 53% of bacteriological culture results, at least one potentially pathogenic 
bacterium was isolated. 
Conclusions: The present study results strengthen the evidence that FOB combined with additional testing of airway specimens 
obtained during FOB is not a powerful tool in the differential diagnosis of chronic cough, and FOB as a diagnostic tool may be 
overused. The appropriate timing and decision regarding referral for FOB and additional testing of achieved material requires 
careful clinical consideration. 
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Introduction
Cough is a protective reflex of the respiratory 
system that clears the airways from mucus, fluids, 
particles or other material [1]. An occasional, 
sporadic cough is normal and healthy. A cough 
that persists for several weeks or one that brings 
the blood, bloody or discolored sputum or an 
excessive amount of airway mucus may indi-
cate a condition that requires medical attention. 
Cough itself belongs to the most frequent respira-
tory symptoms for which patients seek help from 
primary care physicians and/or pulmonologists 
[2]. Taking into account the symptom duration, it 
is subdivided into three categories, namely: acute 
— defined as lasting less than 3 weeks, subacute 
— 3–8 weeks duration, and chronic cough which 
persists longer than 8 weeks [3].
Differential diagnosis of chronic cough in 
the first line should include common causes like 
upper airway cough syndrome (UACS), asthma, 
eosinophilic bronchitis, gastroesophageal reflux 
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disease (GERD), chronic obstructive pulmonary 
disease, pulmonary fibrosis, or bronchiecta-
sis. Additionally, drugs (e.g. ACEI, angioten-
sin-converting enzyme), exposure to cigarette 
smoke and environmental pollution should be 
taken into account [1]. Animal studies indicate 
that cough stress to the airway wall generates 
a self-perpetuating cough-reflex cycle [4]. It is 
of note that the causes of cough may overlap. It 
has been shown in a prospective cohort study of 
patients with chronic cough that this symptom 
was due to one condition in 73%, to two condi-
tions in 23%, and to three conditions in 3% of 
the subjects [5].
According to the most up-to-date ERS guide-
lines on the diagnosis and treatment of chronic 
cough [7], the initial evaluation of a patient 
should include a detailed medical history (most 
importantly ACEI use, smoking history and irri-
tants exposure), physical examination, chest ra-
diography, lung function tests, and conditionally 
FeNo and blood eosinophilia. Recommended ini-
tial management includes: stopping risk factors, 
empirical treatment with oral or inhaled steroids 
or proton pomp inhibitors (PPI) in symptomatic 
GERD [7]. In a patient with normal chest X-ray 
and unsuccessful initial management, additional 
evaluation is suggested, with bronchoscopy at the 
very end of the list, after esophageal manometry, 
induced sputum, sputum acid-fast bacilli (AFB), 
laryngoscopy, methacholine challenge and chest 
CT [6]. Still, fiberoptic bronchoscopy (FOB) 
may be a reasonable tool for the anatomical and 
dynamic assessment of the airways and offers 
a sampling of distal airways for cytologic and 
microbiologic studies.
There is a substantial body of evidence 
suggesting that FOB has a limited role in the 
diagnosis of patients when chronic cough is the 
only indication and when no findings in imaging 
studies are detected [8–10]. However, in selected 
instances, e.g., the necessity of sampling, pres-
ence of risk factors of malignancy, refractory 
cough, in immunocompromised patients or when 
“uncommon causes’’ are considered, the clinical 
benefit of FOB is noted [8, 10–13].
The present study aimed to evaluate the 
utility of FOB and additional testing of samples 
collected using FOB in the differential diagnosis 
of chronic cough. We hypothesize that the visu-
alization of the airways itself is not sufficient to 
determine the underlying cause of chronic cough, 
but reasonably selected additional tests of airway 
samples collected during FOB may increase its 
diagnostic value.
Material and methods
The study is a retrospective, single-center, 
observational cohort study of patients referred 
with a diagnosis of chronic cough to the Bron-
choscopy Unit of the Department of Pneumology 
and Allergy and the Department of General and 
Oncological Pulmonology of Medical Universi-
ty of Lodz FOB examinations were performed 
between November 2006 and April 2017 by 
experienced pulmonologists. During this period, 
7115 conventional white light FOB examinations 
were carried out. The results of examinations 
were routinely collected in a digital database. Due 
to the retrospective nature of the study, no ethics 
committee approval was needed. 
Study inclusion criteria were the following: di-
agnosis of chronic (> 8 weeks) unexplained cough 
as the only indication for FOB and no radiological 
findings (chest radiography and/or chest comput-
ed tomography); aged above 18. Patients with any 
lung-related disease diagnosed before FOB referral 
(e.g. neoplasm, asthma, COPD, sarcoidosis) or pre-
senting with other accompanying symptoms (e.g. 
hemoptysis) were excluded from the study.
All patients’ cases which met study eligibility 
criteria were analyzed. Medical documentation, 
the outcome of FOB examinations and results of 
additional testing of samples collected during 
FOB: tests to exclude tuberculosis infection AFB 
smears and cultures], non-specific microbiologi-
cal cultures of bronchial washings and cytologic 
examinations of bronchoalveolar lavage fluid 
(BALf) were analyzed. 
Drug resistance definitions used in our study 
are based on the previously published definitions 
by Magiorakos [14]. Based on the previously used 
methodology of building worksheets for categoriz-
ing bacteria to a particular group of resistance, we 
created worksheets for bacteria found in our study.
Results
After careful review of the study inclusion 
and exclusion criteria, we have finally enrolled 
198 patients in the study, 121 females (61%) and 
77 males (39%), with the median age of 51.5 years 
(37.75–61). Figure 1 shows the flow chart of pa-
tient selection for the study.
Chronic bronchitis signs were visualized in 
114 (57.6%) patients. The endoscopic diagnosis of 
chronic bronchitis was based on the visual assess-
ment when the following features were present: 
dilated mucus glands’ ducts, atrophic mucosa, 
mucus aggregation, hyperemia, mucosal fragility. 
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In 81 (40.9%) examinations, no visible lesions of 
the airways were noted. In three (1.5%) patients, 
FOB revealed the probable cause of chronic cough: 
suspicion of a tumor (pathology not determined, 
sent to another center and lost to follow-up), 
bronchial polyp, and tracheomalacia (Figure 2).
None of the studied patients had a positive 
result of tuberculosis testing (AFB smear and/or 
culture). In 45 (22.7%) patients, bronchoalveolar 
lavage (BAL) was performed. In 41 cases (91.1%), 
BALf cytologic examination showed at least one 
cell count abnormality, in 12 cases (26.7%), at least 
three abnormalities, see Table 1. In 5 (11.1%) exam-
inations eosinophils count of ≥ 3% was detected.
In 111 (56%) FOB examinations, non-specific 
bacteriological cultures were performed. One 
potentially pathogenic bacterium was detected in 
51 (46%) samples, and 2 potentially pathogenic 
bacteria were detected in 8 (7%) samples. There 
were 2 alert pathogens within cultured bacteria. 
Remaining 52 (46.8%) cultures were sterile.
Multidrug resistance (MDR) was detected in 
case of 40 bacterial strains (59.7%), and in 1 case 
(1.5%), extensive drug resistance (XDR) was iden-
tified. In 21 (36%) patients with positive cultures, 
FOB revealed no visible airway changes. Isolated 
bacterial strains are shown in Table 2.
Discussion
This retrospective, observational, cohort 
study aimed to evaluate the utility of FOB in the 
differential diagnosis of chronic cough. Our study 
results showed that only 1.5% of FOB examina-
tions revealed directly probable cause of chronic 
cough.  57% of the subjects had endoscopic 
signs of chronic bronchitis. However, we need to 
keep in mind that this is a subjective operator’s 
assessment and chronic bronchitis is a clinical 
definition. Therefore, we suggest that such an 
endoscopic conclusion might be overused, espe-
cially when the operator is looking for potential 
cause of chronic cough and does not identify 
any other pathology. It is worth  mentioning that 
according to Markovitz et al., respiratory tract 
inflammation may be induced by the act of cough-
Figure 1. The flow chart showing patient selection to the study
Figure 2. Fiberoptic bronchoscopy outcome
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ing itself [10]. Additionally, 41% of the studied 
subjects had no visible airway changes in FOB. 
Taken together, our results suggest that FOB has 
a limited role in the diagnosis of chronic cough 
as the only indication, which is concordant with 
previously published observations. 
The substantial body of evidence suggests 
that FOB may be overused in the diagnosis of 
respiratory conditions. Sen et al. have suspected 
that unnecessary FOB is most likely overused 
in the evaluation of respiratory symptoms (e.g. 
cough, hemoptysis) [15]. Moreover, Gasparini and 
Barnes have deduced that FOB provides a little 
diagnostic information in the context of patients 
with no radiological findings [8, 9]. It is of note 
that Irwin et al. concluded that FOB has the least 
relative usefulness of the components (e.g. med-
ical history, physical examination, pulmonary 
function testing, upper gastrointestinal studies, 
esophageal pH monitoring, sinus or chest X-rays) 
of the diagnostic protocol of chronic cough [5].
However, many authors, including those 
mentioned above, have agreed that FOB is a very 
useful tool in a properly selected subgroup of 
patients. According to Irwin et al., in case of sus-
picion of malignancy (e.g. smoking or hemoptysis 
history), even if chest radiography is normal, 
FOB is indicated [11]. Moreover, when sampling 
is needed (e.g. BALf, transbronchial biopsy, mi-
crobiologic culture or cytology) FOB is a desired 
technique [2, 5, 8, 15].
Markovitz and Irwin have proposed a simple 
recipe to maximize the yield of FOB and not to 
overuse that examination. They have advised 
performing early FOB only when the radiological 
image is abnormal or when a patient is immuno-
compromised, even if radiological findings are 
absent. Otherwise, delaying FOB until the most 
common causes are excluded, and other diagnostic 
procedures are exhausted, is recommended [10].
Collecting samples from the respiratory tract 
to carry out additional testing to expand the 
diagnostic yield of FOB is a common practice. 
There is a knowledge gap in the literature how 
such sampling and additional testing impact on 
the efficacy of FOB in the differential diagnosis of 
chronic cough. Moreover, clear indications when 
additional testing should be applied are lacking. 
In this retrospective analysis, in 45 (22.7%) cases 
of all 198 FOB examinations, BAL was performed. 
Five results (2.5% of all 198 patients and 11% of 
patients subjected to BAL) of BALf cell counts 
showed an increased number of eosinophils ≥ 
3%. This quantity, but in sputum, is a criterion 
used for the diagnosis of nonasthmatic eosino-
philic bronchitis (NAEB) — one of the probable 
causes of chronic cough. Nevertheless, cytologic 
examination of BALf can equally be used for 
diagnosis of NAEB [16]. Although in our study, 
BALf analysis results were abnormal in almost 
Table 1. BALf cell count analysis 
Normal value Number of abnormal BALf cell count results [n, (%)] Median value (IQR)
All cells < 106 31 (68.9%) 1.4 × 106 (9.8 × 106 – 22.43 × 106)
Neutrophils < 3% 5 (11.1%) 4.3% (3.8–4.65%)
Lymphocytes < 15% 32 (71.1%) 24% (19–29%)
Eosinophils < 0.5% 15 (33.3%) 2% (1–3%)
Monocytes < 0.5% 2 (4.4%) 1% (1%)
Basophils < 0.5% 2 (4.4%) 1.8% (1.2–2.4%)
BALf — bronchoalveolar lavage fluid
Table 2. Bacterial species and number of positive culture 
results from bronchial washings
















Advances in Respiratory Medicine 2020, vol. 88, no. 5, pages 406–411
410 www.journals.viamedica.pl
all patients, the observed abnormalities are not 
characteristic of any specific diagnosis. The 
most commonly observed abnormalities were 
an increased total number of BALf cells and an 
elevated percentage of BALf lymphocytes — the 
finding that is suggestive of many interstitial 
lung diseases [17]. However, according to some 
authors, an increased percentage of lymphocytes 
is a non-specific finding, probably related to the 
cough itself [18]. Both an increased number of 
cells and an elevated percentage of lymphocytes 
may be related to low-grade bronchial inflamma-
tion induced by mechanical insult triggered by 
unrestrained bursts of cough. 
In the case of 111 of all 198 FOB examina-
tions (56%), bronchial washings for cultures 
were collected, 59 (53.1%) of them were positive, 
which potentially could uncover the cause of un-
determined chronic cough. Due to a retrospective 
character of the study, it was impossible to follow 
the patients with positive culture results. Specif-
ically, we do not have any knowledge whether 
the culture-based antibiotic treatment was intro-
duced, and if so, whether was it effective.
Our study results support the use of addi-
tional testing to increase the diagnostic efficacy 
of FOB. The diagnostic yield of FOB increased 
from 1.5% (direct visualization of the tracheo-
bronchial tree) to 33.8% by combining BALf 
cytologic examinations and bronchial washings 
cultures. Similar conclusions were presented 
by Heching et al., who increased the diagnostic 
yield of FOB from 26% to 68% after the addition 
of microbiologic cultures and histopathologic 
analysis of specimens [19]. 
On the other hand, in one study on the utility 
of FOB in the differential diagnosis of chronic 
cough, 27 out of 48 FOB procedures included 
bronchial washings for cultures, and only 3 of 
them were positive. Furthermore, these three pa-
tients were treated with the appropriate course 
of antimicrobials, which has not improved their 
cough. According to the authors, this indicates that 
cultured bacteria have signified contamination, 
colonization, or were not responsible for cough [9].
In the case of our analysis, all 59 positive 
cultures identified a total of 67 bacteria. Among 
them, 40 (59.7%) presented MDR, and 1 (1.5%) 
was XDR. We are unable to determine which and 
how many of these bacteria were causes of chron-
ic cough in the studied cohort, nevertheless, so 
widespread drug resistance might pose a problem 
in bacterial eradication if such a clinical decision 
is undertaken. The simple explanation for so fre-
quent detection of MDR bacterial strains would 
possibly be the common use of antibiotics in 
everyday clinical ambulatory practice in patients 
with cough, however, we do not have any data to 
proof that in our cohort of patients this was true.
Another additional test that is routinely 
performed in patients with chronic cough under-
going FOB is AFB smears and BALf or bronchial 
washings cultures for Mycobacterium tuberculosis 
(MTB). Our results demonstrating none of posi-
tive results for MTB detection clearly show that 
in subjects with normal chest X-ray, and when 
the only symptom was chronic cough, these tests 
were simply useless.
Interestingly, in 21 (36%) of patients with 
positive cultures, FOB revealed no visible airway 
changes. This result may lead to many different 
hypothetical conclusions. Barnes et al. suggest 
that these bacteria can be a contamination, colo-
nization, or do not explain cough [9]. On the other 
hand, if found pathogens are the cause of cough, 
it is a significant argument for collecting samples 
for microbiological cultures during every single 
FOB in such a clinical indication.
Taken together, we and others suggest the 
appropriate balance between the risk and benefits 
of using FOB in the diagnostic process of chronic 
cough. Moreover, when a decision of performing 
FOB is undertaken, additional testing, such as 
microbiological cultures or BALf analysis should 
be considered on the case by case basis. The re-
cently published study by Heching et al. showed 
a marked increase of the diagnostic yield by 
adding microbiological cultures and pathology 
analysis to the visual assessment [20]. The cur-
rent update of “ERS guidelines on the diagnosis 
and treatment of chronic cough in adults and 
children” discuss a non-invasive alternative in 
the diagnosis management. The use of fractional 
exhaled nitric oxide (FeNO) in breath or blood 
eosinophilia have been proposed to assess airway 
eosinophilia, but the evidence is still very low [6].
Limitations 
There are several limitations of our study 
which need to be considered. First of all, as a ret-
rospective, single-institution study, it is saddled 
with all limitations associated with this type of 
data collection, including lack of data or other 
potential confounding factors. Furthermore, cul-
tures were not performed in all studied subjects 
referred for FOB. Moreover, we do not know if 
positive cultures had any impact on how patients 
were treated, what was the outcome of treatment, 
and finally, if cultured microbes were the intrinsic 
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and sole cause of chronic cough. Furthermore, 
agents included in worksheets for categorizing 
bacteria found in our study differ from agents 
used by Magiorakos [14].
Conclusions
The present study results strengthen the evi-
dence that FOB combined with additional testing 
of airway specimens obtained during FOB is not 
a powerful tool in the differential diagnosis of 
chronic cough and may be overused. The appro-
priate timing and decision regarding referral for 
FOB requires careful clinical consideration.  
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